Regulation of Central Nervous System Myeloid-Derived Suppressor Cells in the Crucial Role of Granulocytic

There is a need in autoimmune diseases to uncover the mechanisms involved in the natural resolution of inflammation. In this article, we demonstrate that granulocytic myeloid-derived suppressor cells (G-MDSCs) abundantly accumulate within the peripheral lymphoid compartments and target organs of mice with experimental autoimmune encephalomyelitis prior to disease remission. In vivo transfer of G-MDSCs ameliorated experimental autoimmune encephalomyelitis, significantly decreased demyelination, and delayed disease onset through inhibition of encephalitogenic Th1 and Th17 immune responses. Exposure of G-MDSCs to the autoimmune milieu led to up-regulation of the programmed death 1 ligand that was required for the G-MDSC– mediated suppressive function both in vitro and in vivo. Importantly, myeloid-derived suppressor cells were enriched in the periphery of subjects with active multiple sclerosis and suppressed the activation and proliferation of autologous CD4 + T cells ex vivo. Collectively, this study revealed a pivotal role for myeloid-derived suppressor cells in the regulation of multiple sclerosis, which could be exploited for therapeutic purposes. The Journal of Immunology , 2012, 188: 1136–1146. e-establishment of immune homeostasis and self-tol-erance remain unresolved issues in autoimmune inflammatory diseases. Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS of unknown eti-ology (1). Experimental autoimmune encephalomyelitis CD4 + CD25 2 autologous T cells. These results demonstrated that PD-L1 expression by human CD33 + CD15 + MDSCs might be involved in MDSC-mediated suppression and indicated that other mediators have to participate, because blocking of PD-L1 does not fully restore human T cell proliferation. Overall, our results demonstrated a significant enrichment of G-MDSCs in active MS patients with a potent ability to suppress the activation and expansion of autologous T cells.

[1]  A. Sharpe,et al.  Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune Disease , 2012, The Journal of Immunology.

[2]  T. Ratliff,et al.  In vivo suppressive function of myeloid‐derived suppressor cells is limited to the inflammatory site , 2011, European journal of immunology.

[3]  D. Gabrilovich,et al.  Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. , 2011, Trends in immunology.

[4]  C. Divino,et al.  Myeloid-Derived Suppressor Cells Prevent Type 1 Diabetes in Murine Models , 2010, The Journal of Immunology.

[5]  J. Ochando,et al.  Myeloid-derived suppressor cells: natural regulators for transplant tolerance. , 2010, Human immunology.

[6]  Je-in Youn,et al.  The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity , 2010, European journal of immunology.

[7]  David H. Lee,et al.  Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells , 2010, The Journal of Immunology.

[8]  F. Ginhoux,et al.  Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. , 2010, The Journal of clinical investigation.

[9]  S. Bicciato,et al.  Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. , 2010, Immunity.

[10]  Loise M. Francisco,et al.  The PD‐1 pathway in tolerance and autoimmunity , 2010, Immunological reviews.

[11]  S. Sandwick,et al.  Subsets, expansion and activation of myeloid-derived suppressor cells , 2010, Medical Microbiology and Immunology.

[12]  Lawrence Steinman,et al.  T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis , 2010, Nature Medicine.

[13]  V. Bronte,et al.  Myeloid-derived suppressor cell heterogeneity and subset definition. , 2010, Current opinion in immunology.

[14]  E. Celis,et al.  Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells , 2010, The Journal of Immunology.

[15]  R. Strieter,et al.  IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. , 2010, The Journal of clinical investigation.

[16]  C. Leclerc,et al.  Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. , 2009, Immunity.

[17]  Je-in Youn,et al.  Regulatory myeloid suppressor cells in health and disease. , 2009, Cancer research.

[18]  G. Cheng,et al.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.

[19]  A. Mildner,et al.  CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. , 2009, Brain : a journal of neurology.

[20]  Irah L. King,et al.  Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. , 2009, Blood.

[21]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[22]  A. Mildner,et al.  CCR 2 + Ly-6 Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system , 2009 .

[23]  M. McGeachy,et al.  Cytokines that regulate autoimmunity. , 2008, Current opinion in immunology.

[24]  A. Dick,et al.  Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. , 2008, Journal of autoimmunity.

[25]  G. Bhagat,et al.  Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. , 2008, Cancer cell.

[26]  J. Russell,et al.  Regional CNS responses to IFN-γ determine lesion localization patterns during EAE pathogenesis , 2008, The Journal of experimental medicine.

[27]  Michelle Collazo,et al.  Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.

[28]  M. Manns,et al.  Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. , 2008, Gastroenterology.

[29]  V. Bronte,et al.  Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells , 2008, Immunological reviews.

[30]  G. Freeman,et al.  PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.

[31]  P. De Baetselier,et al.  Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. , 2008, Blood.

[32]  J. Goverman,et al.  Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells , 2008, Nature Medicine.

[33]  M. Zöller,et al.  The Importance of Myeloid-Derived Suppressor Cells in the Regulation of Autoimmune Effector Cells by a Chronic Contact Eczema1 , 2007, The Journal of Immunology.

[34]  S. Youssef,et al.  Type II monocytes modulate T cell–mediated central nervous system autoimmune disease , 2007, Nature Medicine.

[35]  L. Moldawer,et al.  MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis , 2007, The Journal of experimental medicine.

[36]  G. Rabinovich,et al.  Immunosuppressive strategies that are mediated by tumor cells. , 2007, Annual review of immunology.

[37]  M. Leach,et al.  PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis , 2007, Journal of Neuroimmunology.

[38]  V. Kuchroo,et al.  CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. , 2007, Journal of immunology.

[39]  L. Steinman Erratum: A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.

[40]  M. Colombo,et al.  The terminology issue for myeloid-derived suppressor cells. , 2007, Cancer research.

[41]  Paolo Serafini,et al.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. , 2006, The Journal of clinical investigation.

[42]  Hans Lassmann,et al.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.

[43]  G. Freeman,et al.  Tissue expression of PD-L1 mediates peripheral T cell tolerance , 2006, The Journal of experimental medicine.

[44]  Paolo Serafini,et al.  Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. , 2006, Seminars in cancer biology.

[45]  C. Divino,et al.  Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. , 2006, Cancer research.

[46]  J. Leips,et al.  Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression1 , 2006, The Journal of Immunology.

[47]  J. Chameau Corrections , 2006, Nature.

[48]  S. Segal,et al.  CD11b+/Gr-1+ Immature Myeloid Cells Mediate Suppression of T Cells in Mice Bearing Tumors of IL-1β-Secreting Cells1 , 2005, The Journal of Immunology.

[49]  L. A. Stephens,et al.  Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System1 , 2005, The Journal of Immunology.

[50]  L. Steinman,et al.  Design of effective immunotherapy for human autoimmunity , 2005, Nature.

[51]  T. Owens,et al.  Neutrophils That Infiltrate the Central Nervous System Regulate T Cell Responses1 , 2005, The Journal of Immunology.

[52]  R. Hohlfeld,et al.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Freeman,et al.  PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[54]  津田 泰宏 Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus , 2004 .

[55]  O. Finn,et al.  Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. , 2001, Cancer research.

[56]  R. Coffman,et al.  Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.

[57]  Nicholas R. English,et al.  Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.

[58]  S. Wittmer,et al.  Failure to Suppress the Expansion of the Activated Cd4 T Cell Population in Interferon γ–Deficient Mice Leads to Exacerbation of Experimental Autoimmune Encephalomyelitis , 2000, The Journal of experimental medicine.

[59]  J. Antel,et al.  Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. , 2000, Journal of neuropathology and experimental neurology.

[60]  H. Weiner,et al.  IL-4-Deficient and Transgenic Mice Demonstrated by Studies of IL-10- and Autoimmune Encephalomyelitis as IL-10 Is Critical in the Regulation of , 1998 .

[61]  W. Cowden,et al.  IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. , 1996, Journal of immunology.

[62]  A. Billiau,et al.  Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon‐γ , 1996, European journal of immunology.

[63]  L Steinman,et al.  Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.

[64]  L. Steinman,et al.  Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). , 1996, Journal of immunology.

[65]  Meijuan Zhao,et al.  Interferon-γ-Induced Oligodendrocyte Cell Death: Implications for the Pathogenesis of Multiple Sclerosis , 1995, Molecular medicine.

[66]  R. Knobler,et al.  Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. , 1993, Autoimmunity.

[67]  R. Hirsch,et al.  EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.

[68]  J. Mussini,et al.  [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.